GlassScriptPhysician profile
Jonathan B John
NPI 1891732814
$20,555.80
in general payments reported to CMS, 2019-2025
8 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,740 · 2020: $9,355 · 2021: $220 · 2022: $132 · 2023: $8,801 · 2024: $62.69 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,776 · Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,776.00 |
| Food and Beverage | $332.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $19,950.70 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.99 | 2019 | |
| Sanofi Pasteur INC. | $121.84 | 2025 | |
| Abbott Laboratories | $120.72 | 2021 | |
| Boston Scientific Corporation | $98.92 | 2025 | Cds - Mct/Cem Monitoring |
| Abiomed | $62.69 | 2024 | Impella |
| Actelion Pharmaceuticals US, INC. | $51.38 | 2019 | |
| Azurity Pharmaceuticals, INC. | $24.56 | 2025 | Katerzia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.